Eyepoint Pharmaceuticals (NASDAQ:EYPT – Get Free Report) announced its quarterly earnings results on Wednesday. Eyepoint Pharmaceuticals had a negative net margin of 3,566.63% and a negative return on equity of 110.54%. Eyepoint Pharmaceuticals has a one year low of $9.65 and a one year high of $19.11. Eyepoint Pharmaceuticals Company Profile(Get Free Report)Eyepoint Pharmaceuticals, Inc is a biopharmaceutical company focused on the development and commercialization of therapies for the treatment of ocular diseases. See AlsoReceive News & Ratings for Eyepoint Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eyepoint Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.